Saturday 17 October 2026
Export PULM’s income statement to Excel — free account
Pulmatrix, Inc.
PULM Healthcare Biotechnology
Pulmatrix, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $7.8 million, up 6.96% from fiscal 2023. In the quarter to June 2026, revenue fell 99.9%, EPS grew 31.0% and free cash flow grew 41.3%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.
1.36
0.05
−3.55%
Follow PULM
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
— | 4 | 3 | 3 | 4 | 5 | 6 | 3 | 2 | 3 |
Altman Z-Score |
— | (27.85) | (12.22) | (8.94) | (4.83) | (7.00) | (9.20) | (20.97) | (16.15) | (17.30) |
P/S ratio |
— | 3.27 | 0.98 | 2.42 | 4.59 | 2.71 | 1.78 | 14.85 | 35.56 | 10.65 |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.54 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
— | (88.66) | (26.07) | (16.25) | (6.42) | (16.00) | (20.24) | (47.89) | (41.68) | (39.33) |
Beneish M-Score |
— | — | (0.44) | 11.81 | (2.42) | (3.35) | — | — | (4.88) | — |
P/Operating CF |
— | (20.21) | (3.54) | (2.91) | (5.40) | (12.36) | (3.25) | (2.38) | (8.57) | (3.55) |
P/B ratio |
— | 2.85 | 0.40 | 0.47 | 0.51 | 1.48 | 1.31 | 0.84 | 2.71 | 1.02 |
Price to Tangible BV |
— | 4.75 | 0.49 | 0.53 | 0.55 | 1.75 | 1.93 | 9.91 | 0.00 | 0.00 |
EV/Sales |
— | 2.60 | (1.06) | (2.76) | (4.99) | 0.55 | (0.59) | 17.49 | 37.46 | 12.59 |
EV/EBITDA |
— | 0.00 | 0.58 | 0.96 | 1.68 | 0.00 | 0.37 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | (1.89) | 0.48 | 0.87 | 1.31 | (0.55) | (1.46) | (0.70) | (2.00) | (0.79) |
EV/FCF |
— | (1.83) | 0.46 | 0.86 | 1.29 | (0.54) | (1.49) | (0.69) | (1.99) | (0.77) |
Quick Ratio |
12.43 | 10.25 | 5.14 | 7.38 | 12.14 | 3.88 | 1.78 | 0.89 | 0.61 | 0.94 |
Current Ratio |
12.55 | 10.68 | 5.33 | 7.60 | 12.33 | 3.97 | 1.83 | 1.14 | 0.73 | 1.02 |
Net Debt/EBITDA |
0.79 | 1.02 | 1.45 | 2.06 | 3.51 | 3.59 | 1.85 | 0.13 | 0.02 | (0.08) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 20.16% | 34.83% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.32 | 0.66 |
Asset Turnover |
0.00 | 0.36 | 0.19 | 0.12 | 0.11 | 0.34 | 0.31 | 0.01 | 0.02 | 0.03 |
Operating CF/Net income |
1.05 | 1.12 | 1.13 | 1.03 | 0.84 | 0.65 | (0.16) | 0.82 | 0.80 | 0.48 |
Capex/Depreciation |
— | (0.91) | (0.46) | (0.06) | (0.03) | (0.27) | (0.01) | (0.06) | (0.30) | (0.08) |
Interest Coverage |
— | — | — | (61.32) | (2,881.00) | (120.27) | (68.74) | (109.68) | (27.18) | (28.22) |
| (80.93%) | (70.96%) | (57.51%) | (48.62%) | (67.24%) | (113.05%) | (180.17%) | (187.10%) | (191.09%) | (134.61%) | |
| (73.31%) | (43.55%) | (37.70%) | (37.76%) | (48.23%) | (52.05%) | (81.05%) | (133.96%) | (110.63%) | (90.49%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (137.38%) | (111.36%) | (149.69%) |
Return on Tangible Assets |
(135.84%) | (106.32%) | (78.05%) | (56.46%) | (46.13%) | (78.34%) | (142.17%) | (2,586.54%) | 1,842.45% | (3,110.95%) |
Average Days of Receivables |
— | 0.00 | 46.41 | 78.04 | 4.73 | 2.43 | 332.24 | 0.00 | 1.09 | 90.05 |
Research and Development Expense of Revenue |
0.00% | 91.80% | 212.63% | 300.44% | 297.58% | 123.55% | 162.39% | 8,474.51% | 3,057.61% | 1,215.81% |
Selling, General and Administrative Expense of Revenue |
0.00% | 99.73% | 89.34% | 111.65% | 123.37% | 54.51% | 107.32% | 4,913.73% | 2,258.81% | 959.88% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 | 0.10 | 0.74 | 0.68 | 0.66 |
Share Based Compensation of Revenue |
0.00% | 6.55% | 13.07% | 18.35% | 22.40% | 9.17% | 26.12% | 1,943.14% | 841.19% | 478.80% |
Graham Net Nets |
— | 0.35 | 0.69 | 1.93 | 1.83 | 0.51 | 0.44 | 0.04 | (0.06) | (0.35) |
Graham Number |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | (37.39%) | (197.95%) | (128.17%) | (86.56%) | (56.58%) | (174.42%) | (205.38%) | (66.06%) | (312.01%) |
Free Cash Flow Yield |
— | (43.60%) | (234.08%) | (132.36%) | (84.08%) | (37.30%) | 22.04% | (169.84%) | (52.85%) | (153.78%) |
Revenue per Share |
0.00 | 2.14 | 2.00 | 1.76 | 1.91 | 8.79 | 9.45 | 0.74 | 3.46 | 11.27 |
Operating CF per Share |
(1.49) | (2.93) | (4.38) | (5.61) | (7.28) | (8.68) | 3.86 | (81.25) | (149.40) | (178.72) |
Capex per Share |
0.00 | (0.11) | (0.19) | (0.02) | (0.05) | (0.20) | (0.07) | (0.09) | (0.76) | (5.82) |
Free Cash Flow per Share |
(1.49) | (3.04) | (4.56) | (5.64) | (7.34) | (8.88) | 3.79 | (81.34) | (150.17) | (184.53) |
Cash per Share |
1.12 | 2.61 | 5.25 | 10.38 | 19.87 | 22.01 | 28.01 | 12.42 | 36.64 | 56.44 |
Shareholders Equity per Share |
1.04 | 2.45 | 4.93 | 9.02 | 17.52 | 16.09 | 13.17 | 57.41 | 104.61 | 118.23 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.04 | 2.45 | 4.93 | 9.02 | 17.52 | 16.09 | 13.17 | 57.41 | 104.61 | 118.23 |
Free Cash Flow |
(5.43) | (11.11) | (16.66) | (19.44) | (19.87) | (12.76) | 3.17 | (16.78) | (14.55) | (13.67) |
Working Capital |
3.80 | 8.99 | 16.93 | 33.13 | 50.34 | 24.28 | 14.22 | 0.40 | (1.59) | 0.11 |
Capital Expenditures |
— | (0.40) | (0.68) | (0.09) | (0.14) | (0.28) | (0.06) | (0.02) | (0.07) | (0.43) |
Net Current Asset Value |
3.80 | 8.92 | 4.88 | 28.30 | 43.41 | 17.51 | 6.34 | 0.40 | (1.59) | (3.14) |
EV/EBIT |
— | 0.00 | 0.52 | 0.88 | 1.28 | 0.00 | 0.23 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | 0.05 | 0.09 | 0.01 | 0.03 | 0.02 | 0.01 | 0.12 | 0.22 | 0.52 |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
— | 0.00 | 1.27 | 6.57 | 14.99 | 2.89 | 29.75 | 0.76 | 0.40 | 6.72 |
Cash ROIC |
(68.79%) | (60.18%) | (44.83%) | (29.07%) | (19.62%) | (23.29%) | 9.21% | (116.47%) | (86.06%) | (72.94%) |
Accounts Receivable Turnover |
— | 0.00 | 6.56 | 8.90 | 68.46 | 3.47 | 2.20 | 0.00 | 3.24 | 8.07 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | — | — | — | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | — | — | — | — | — | — |
Average Receivables |
— | — | 1.11 | 0.68 | 0.08 | 3.64 | 3.60 | — | 0.10 | 0.10 |
Average Payables |
0.54 | 1.36 | 1.55 | 1.01 | 0.85 | 0.73 | 0.89 | 0.82 | 0.60 | 0.92 |
Average Assets |
7.04 | 21.95 | 37.46 | 49.89 | 48.46 | 37.10 | 25.41 | 15.35 | 16.32 | 30.77 |
Average Common Equity |
6.38 | 13.47 | 24.55 | 38.74 | 34.75 | 17.08 | 11.43 | 10.99 | 9.45 | 20.68 |
Columns are period end dates